Vancouver, British Columbia–(Newsfile Corp. – March 30, 2021) – Tevano Systems Holdings Inc. (CSE: TEVO) (“Tevano“, or the “Company“), is pleased to provide a corporate update on its technology and sales & marketing initiatives of the company.
“At Tevano, we have now moved beyond the R&D phase with our core technology and have built what we believe is a strong foundation, not only with our Health Shield health tracking device and enterprise software but also with our team, supply chain and go to market strategy. Sales and marketing will be a primary focus of the Company over the coming months to capture a strong share of the growing market for health screening technologies and deliver maximum value to our shareholders. We believe we have an enviable combination of technology, talent and market opportunity and plan to aggressively take advantage of this going forward,” said David Bajwa, CEO Tevano.
During the month of March 2021, the Company completed its reverse merger transaction with RBI Ventures Ltd. and subsequently listed its securities on the Canadian Securities Exchange on March 19th, 2021. The Company listed 74,204,564 shares after raising more than $5,000,000 since June of 2020. Approximately 33,467,665 of these shares or 45.10% are held under an escrow agreement and voluntary pooling agreement with release dates ranging from 24 to 36 months for certain shareholders and management of the Company. After listing, pursuant to warrants exercised, the Company issued an additional 1,666,667 shares.
Tevano moved its Health Shield fever detection and thermal scanning technology from a beta release in the summer of 2020 through to full commercialization by the end of December 2020.
Since the start of 2021, Tevano has made continued advancements to its technology including the introduction and implementation of two (2) independent AI engines in order to provide the highest quality and most reliable data for analytics to accommodate the numerous operating conditions and environments that Health Shield operates within.
Further advancements to its proprietary cloud-based operating system have enhanced the ease of use and provided a new level of sophistication to back-end tool sets, allowing users of Health Shield a seamless experience from out of the box through to integration into the business’s operating environments.
Sales & Marketing
The Company has continued to invest in strategic sales and marketing initiatives in both Canada and the United States and the Health Shield device is already successfully deployed within several industry verticals including retail, warehousing & logistics, entertainment venues and long-term care facilities.
The Health Shield has been featured by multiple national news, business and trade media outlets including CTV, BC Business Magazine, Business in Vancouver & IOSH Magazine and OHS Online. Up to date news and media coverage can be viewed here.
In Western Canada, the Company is spearheading sales from its head office located in Vancouver, BC. Eastern Provinces will be headed up through sales efforts located in St. Johns, New Brunswick.
In the US, Tevano intends on developing its Eastern US sales initiatives through Dental Technology Integrators, Inc. (dba as Dental TI and Medical TI). Supplying the medical and dental equipment markets, Dental Technology Integrators, Inc. is an Indiana-based supplier of dental and medical equipment and devices to thousand of clients across the United States.
Moving forward, Tevano plans to continue to advance its technology through ongoing product development as well as utilizing proprietary technology that has already been developed to augment its products in order to expand its product offering in a post Covid environment. The Company anticipates sales and marketing initiatives will continue through organic initiatives and well as the expansion of dealer networks across Canada and the United States.
Tevano is the developer of Health Shield™, an innovative AI-driven electronic device that provides instant body temperature scanning and notifies users if they need to wear a face mask. Health Shield™ devices can be placed at all entrances that patrons and/or employees use to gain access to buildings. The Health Shield™ device is supported by a cloud software solution that can be used to manage multiple devices and provide detailed reporting and analysis. Tevano benefits from an equity-based relationship with kiosk and screen-based technology leader, Nevatronix. Management believes the relationship provides Tevano with access to highly robust supply chains and gives the company a unique capacity to react to and service evolving commercial markets for health tracking technologies.
For more information, please visit www.tevano.com
For media requests, please contact email@example.com or call 416-628-7441
On behalf of the Board of:
TEVANO SYSTEMS HOLDINGS INC
David Bajwa, Chief Executive Officer
778 388 4806
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release contains forward‐looking statements and forward‐looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward‐looking statements or information. More particularly and without limitation, this news release contains forward‐looking statements and matters. The forward‐looking statements and information are based on certain key expectations and assumptions made by management of the Company. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward‐looking statements and information since no assurance can be given that they will prove to be correct.
Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward‐looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to raise further capital and the Company’s ability to obtain regulatory and exchange approvals. Accordingly, readers should not place undue reliance on the forward‐looking statements and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive. The forward‐looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward‐looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.
Neither the CSE nor the Investment Industry Regulatory Organization of Canada accepts responsibility for the adequacy or accuracy of this release.